Literature DB >> 2570093

Endocrine therapy of metastatic breast cancer.

A Manni1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570093     DOI: 10.1007/BF03350007

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


× No keyword cloud information.
  114 in total

1.  Treatment of breast cancer with gonadotropin-releasing hormone.

Authors:  A Manni; R Santen; H Harvey; A Lipton; D Max
Journal:  Endocr Rev       Date:  1986-02       Impact factor: 19.871

2.  Effects of anti-estrogens on bone in castrated and intact female rats.

Authors:  V C Jordan; E Phelps; J U Lindgren
Journal:  Breast Cancer Res Treat       Date:  1987-10       Impact factor: 4.872

3.  Effects of estrogens and antiestrogens on estrogen receptor dynamics and the induction of progesterone receptor in MCF-7 human breast cancer cells.

Authors:  R L Eckert; B S Katzenellenbogen
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

4.  Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.

Authors:  S M Swain; R A Sorace; C S Bagley; D N Danforth; J Bader; M N Wesley; S M Steinberg; M E Lippman
Journal:  Cancer Res       Date:  1987-07-15       Impact factor: 12.701

5.  Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer.

Authors:  F Cavalli; A Goldhirsch; F Jungi; G Martz; P Alberto
Journal:  J Clin Oncol       Date:  1984-05       Impact factor: 44.544

6.  Interaction of non-steroidal antiestrogens with dopamine receptor binding.

Authors:  C Hiemke; R Ghraf
Journal:  J Steroid Biochem       Date:  1984-12       Impact factor: 4.292

7.  Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.

Authors:  A V Schally; T W Redding
Journal:  Proc Natl Acad Sci U S A       Date:  1987-10       Impact factor: 11.205

8.  Treatment of acromegaly with the long-acting somatostatin analog SMS 201-995.

Authors:  A L Barkan; R P Kelch; N J Hopwood; I Z Beitins
Journal:  J Clin Endocrinol Metab       Date:  1988-01       Impact factor: 5.958

9.  Low-dose aminoglutethimide without steroid replacement in the treatment of postmenopausal women with advanced breast cancer.

Authors:  R Murray; P Pitt
Journal:  Eur J Cancer Clin Oncol       Date:  1985-01

10.  Controlled trial of tamoxifen as a single adjuvant agent in the management of early breast cancer. 'Nolvadex' Adjuvant Trial Organisation.

Authors: 
Journal:  Br J Cancer       Date:  1988-06       Impact factor: 7.640

View more
  3 in total

1.  Truncated forms of DNA-binding estrogen receptors in human breast cancer.

Authors:  G K Scott; P Kushner; J L Vigne; C C Benz
Journal:  J Clin Invest       Date:  1991-08       Impact factor: 14.808

2.  cDNA transfection followed by the isolation of a MCF-7 breast cell line resistant to tamoxifen in vitro and in vivo.

Authors:  M Toi; A L Harris; R Bicknell
Journal:  Br J Cancer       Date:  1993-12       Impact factor: 7.640

3.  Determination of oestrogen responsiveness of breast cancer by competitive reverse transcription-polymerase chain reaction.

Authors:  M Carr; F E May; T W Lennard; B R Westley
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.